SCHEMBL19082343

SCHEMBL19082343

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5ccc6c(c5)sc5cc7sc8ccc9ccccc9c8c7cc56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 3/20 0.36
ESR1 P03372 5/20 0.34
ESR2 Q92731 5/20 0.34
NQO2 P16083 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP1A1 P04798 2/20 0.33
HSD17B1 P14061 2/20 0.33
HSD17B2 P37059 2/20 0.33
NQO1 P15559 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP1B1 Q16678 1/20 0.33
MCL1 Q07820 1/20 0.33
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082201 0.98 F9 (0.39) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082341 0.96 F9 (0.36) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082286 0.95 ESR1 (0.35) F9ESR1ESR2NQO2CYP1A1
SCHEMBL19082217 0.95 F9 (0.37) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082145 0.95 F9 (0.35) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082171 0.94 HSD17B1 (0.35) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082196 0.94 F9 (0.39) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082337 0.94 ESR1 (0.35) F9ESR1ESR2NQO2CYP1A2
SCHEMBL19082131 0.94 NQO2 (0.35) F9ESR1ESR2NQO2CYP1A2
SCHEMBL17943984 0.92 F9 (0.39) F9ESR1ESR2NQO2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 F9 1203/4885ESR1 225/4885ESR2 542/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 F9 1203/4885ESR1 225/4885ESR2 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.